scholarly article | Q13442814 |
P50 | author | James S. Pankow | Q30348349 |
Joseph A Delaney | Q58051654 | ||
Aaron R. Folsom | Q71098091 | ||
Russell P Tracy | Q86752125 | ||
Christopher J O'Donnell | Q89928448 | ||
James G. Wilson | Q92206045 | ||
Herman A Taylor | Q97552746 | ||
Geoffrey H Tofler | Q114300854 | ||
Leslie A. Lange | Q115055812 | ||
David R. Jacobs | Q39377503 | ||
Mary Cushman | Q40845084 | ||
P2093 | author name string | Nicholas L Smith | |
Weihong Tang | |||
Stephen S Rich | |||
Qiong Yang | |||
Cameron D Palmer | |||
David Green | |||
Saonli Basu | |||
Alexander P Reiner | |||
Brendan J Keating | |||
Lu-Chen Weng | |||
Taylor Young | |||
P2860 | cites work | PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 |
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
The Cardiovascular Health Study: design and rationale | Q29614874 | ||
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project | Q30411744 | ||
Candidate gene association resource (CARe): design, methods, and proof of concept | Q30432077 | ||
Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes | Q30535420 | ||
The framingham offspring study. Design and preliminary data | Q30700098 | ||
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies | Q33381588 | ||
GWAF: an R package for genome-wide association analyses with family data | Q33521158 | ||
Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time | Q33772986 | ||
Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease | Q61784138 | ||
Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study | Q67875630 | ||
Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study | Q72396963 | ||
The genetics of haemostasis: a twin study | Q73485873 | ||
A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels | Q73883397 | ||
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time | Q74152605 | ||
Heritability of hemostasis phenotypes and their correlation with type 2 diabetes status in Mexican Americans | Q81096675 | ||
Homocysteine and thrombosis: from basic science to clinical evidence | Q81641886 | ||
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium | Q33817075 | ||
Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia | Q34144305 | ||
Elevated factor VIII levels and the risk of thrombosis | Q34248938 | ||
Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association | Q34319603 | ||
Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies | Q34352963 | ||
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. | Q34548039 | ||
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe). | Q34568873 | ||
Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort | Q35029443 | ||
Structure and function of the factor VIII gene and protein | Q35086356 | ||
Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study | Q35802242 | ||
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels | Q35804461 | ||
Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease | Q36096131 | ||
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. | Q36166323 | ||
Activated partial thromboplastin time and risk of future venous thromboembolism | Q36542496 | ||
Testing for association on the X chromosome | Q36877021 | ||
A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array | Q36929932 | ||
von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. | Q37112364 | ||
Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study | Q37353655 | ||
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium | Q37708719 | ||
CARDIA: study design, recruitment, and some characteristics of the examined subjects | Q39292643 | ||
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. | Q43458565 | ||
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study | Q44734148 | ||
Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators | Q46452094 | ||
Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. | Q46829416 | ||
Genetic variants associated with Von Willebrand factor levels in healthy men and women identified using the HumanCVD BeadChip | Q46970043 | ||
von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population | Q47793649 | ||
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. | Q51773327 | ||
The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels. | Q53867811 | ||
Genetic determinants of hemostasis phenotypes in Spanish families. | Q54056926 | ||
Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes | Q57312436 | ||
A Genome-Wide Association Study Identifies KNG1 as a Genetic Determinant of Plasma Factor XI Level and Activated Partial Thromboplastin Time | Q57315828 | ||
Recruitment of adults 65 years and older as participants in the cardiovascular health study | Q57392546 | ||
KNG1 Ile581Thr and susceptibility to venous thrombosis | Q57605719 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 534-540 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | American Journal of Hematology | Q4744246 |
P1476 | title | Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans | |
P478 | volume | 90 |
Q57094753 | Common sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD |
Q39040002 | Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels |
Q30000298 | Genomic Contributors to Rhythm Outcome of Atrial Fibrillation Catheter Ablation - Pathway Enrichment Analysis of GWAS Data |
Q40227354 | Identification of coagulation gene 3'UTR variants that are potentially regulated by microRNAs |
Q28607764 | Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF |
Q49246959 | Regulation of plasma von Willebrand factor. |
Search more.